BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2056976)

  • 1. Rhabdoid tumor of the central nervous system.
    Perilongo G; Sutton L; Czaykowski D; Gusnard D; Biegel J
    Med Pediatr Oncol; 1991; 19(4):310-7. PubMed ID: 2056976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonenhancing primary central nervous system lymphoma.
    Terae S; Ogata A
    Neuroradiology; 1996 Jan; 38(1):34-7. PubMed ID: 8773272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetization transfer contrast imaging of brain tumors].
    Lundbom N; Kurki T; Komu M; Kormano M
    Rontgenpraxis; 1995 Feb; 48(2):42-4. PubMed ID: 7709289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Magnetic resonance tomography in the diagnosis of space-occupying formations in the posterior cranial fossa].
    Turkin AM; Klimchuk OV; Mukhametzhanov D; Korshunov AG
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (1):12-6. PubMed ID: 8711962
    [No Abstract]   [Full Text] [Related]  

  • 6. Perineural extension of nasopharyngeal carcinoma into the posterior cranial fossa detected by magnetic resonance imaging.
    Mineura K; Kowada M; Tomura N
    Clin Imaging; 1991; 15(3):172-5. PubMed ID: 1933644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of MRI with Gd-DTPA in brain tumors].
    Sakamoto Y; Takahashi M; Miyawaki M; Bussaka H; Wakamatsu H
    Rinsho Hoshasen; 1988 Apr; 33(4):435-8. PubMed ID: 3398269
    [No Abstract]   [Full Text] [Related]  

  • 9. Indications for the use of Gd-DTPA in MRI of the central nervous system. Experiences in patients with cerebral and spinal diseases.
    Bauer WM; Fenzl G; Vogl T; Fink U; Lissner J
    Invest Radiol; 1988 Sep; 23 Suppl 1():S286-8. PubMed ID: 3198363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
    Schubeus P; Schörner W; Haustein J
    Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
    [No Abstract]   [Full Text] [Related]  

  • 12. CNS imaging of neoplasms.
    Bragg DG; Osborn AG
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):841-5. PubMed ID: 1869474
    [No Abstract]   [Full Text] [Related]  

  • 13. Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
    Powers TA; Partain CL; Kessler RM; Freeman MW; Robertson RH; Wyatt SH; Whelan HT
    Radiology; 1988 Dec; 169(3):723-6. PubMed ID: 3055036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of contrast agents in the evaluation of neoplasms of the central nervous system.
    Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Mayr NA
    Top Magn Reson Imaging; 1992 Sep; 4(4):1-6. PubMed ID: 1419031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paramagnetic contrast agents in the evaluation of brain neoplasms.
    Hinshaw DB; Wong VC
    Top Magn Reson Imaging; 1989 Mar; 1(2):79-93. PubMed ID: 2624774
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous involution of an intra-axial brain stem lesion: a case report.
    Rao S; Constantini S; Gomori JM; Siegal T; Epstein F
    Pediatr Neurosurg; 1995; 23(5):279-81; discussion 282. PubMed ID: 8688354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd DTPA. Clinical efficacy.
    Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas.
    Moghrabi A; Kerby T; Tien RD; Friedman HS
    Pediatr Neurosurg; 1995; 23(6):293-8. PubMed ID: 8743997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.